I'm contacting you to recommend the inclusion of MariMed Inc. (MRMD) in your portfolio to benefit from the potential DEA rescheduling and the resulting growth in the medical cannabis industry on the stock market. I own 10,000 shares....

MRMD: MariMed Inc.

Low Debt for Financial Stability: MRMD operates with minimal debt, ensuring sustainable growth and resilience in a rapidly changing market. The price is low compared to the number of shares outstanding with limited dilution.

Proven Expertise with Medical Licenses: A strong track record in cultivation, processing, and retail, supported by necessary state and medical licenses.

Diverse and High-Quality Product Portfolio: MRMD offers gummies, RSO, live resin, flower, and other medical-grade cannabis products, catering to a wide range of patient needs.

Ready for Insurance Integration: Positioned to take advantage of regulatory changes that would enable FDA-approved products to be prescribed and covered by insurance.

Seamless Distribution through Major Pharmacies and Hospitals: MRMD holds medical licenses to distribute cannabis products to major pharmacy stores like Walgreens, CVS, and Hospitals making co-pays accessible to patients with the help of insurance much like any other medication. Dentists can also benefit by administering medication for oral surgery.

Rescheduling cannabis would improve FDA validation, insurance coverage, and broader patient access. MariMed Inc. (MRMD) is a leader in this transition, making it a strong addition to your portfolio.